[
  {
    "ts": null,
    "headline": "Those who invested in AbbVie (NYSE:ABBV) five years ago are up 126%",
    "summary": "It hasn't been the best quarter for AbbVie Inc. ( NYSE:ABBV ) shareholders, since the share price has fallen 11% in...",
    "url": "https://finnhub.io/api/news?id=ce93beced420530f310a7dd6186a4be38c584ae1e358666a2fc887fb029de5c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751108420,
      "headline": "Those who invested in AbbVie (NYSE:ABBV) five years ago are up 126%",
      "id": 135615646,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "It hasn't been the best quarter for AbbVie Inc. ( NYSE:ABBV ) shareholders, since the share price has fallen 11% in...",
      "url": "https://finnhub.io/api/news?id=ce93beced420530f310a7dd6186a4be38c584ae1e358666a2fc887fb029de5c3"
    }
  },
  {
    "ts": null,
    "headline": "Got $500? 2 Healthcare Stocks to Buy and Hold Forever",
    "summary": "Abbott Laboratories provides exposure to multiple areas of healthcare.  The healthcare sector is an ideal place for long-term investors to focus their attention, in my view.  You won't need a fortune to get started investing in the healthcare sector.",
    "url": "https://finnhub.io/api/news?id=816f51c36c1d24fc79b428f64c3d83c9ad592e63df6495de83a65b56ff6ec14d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751104140,
      "headline": "Got $500? 2 Healthcare Stocks to Buy and Hold Forever",
      "id": 135615648,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Abbott Laboratories provides exposure to multiple areas of healthcare.  The healthcare sector is an ideal place for long-term investors to focus their attention, in my view.  You won't need a fortune to get started investing in the healthcare sector.",
      "url": "https://finnhub.io/api/news?id=816f51c36c1d24fc79b428f64c3d83c9ad592e63df6495de83a65b56ff6ec14d"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie’s Elahere Market Expected to Skyrocket to $6B by 2034 in Ovarian Cancer Treatment",
    "summary": "AbbVie Inc. (NYSE:ABBV) is one of the undervalued S&P 500 stocks to buy according to hedge funds. On June 25, the “Elahere Market Opportunities and Strategies to 2034” report was added to ResearchAndMarkets.com’s offering. It stated that the global market for Elahere, which is a treatment primarily for ovarian cancer, is anticipated to experience rapid […]",
    "url": "https://finnhub.io/api/news?id=b1a46e20d9b18ac03eeb4ae6bd70e25137702f520796f283b17c6249e752a21b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751098543,
      "headline": "AbbVie’s Elahere Market Expected to Skyrocket to $6B by 2034 in Ovarian Cancer Treatment",
      "id": 135615650,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie Inc. (NYSE:ABBV) is one of the undervalued S&P 500 stocks to buy according to hedge funds. On June 25, the “Elahere Market Opportunities and Strategies to 2034” report was added to ResearchAndMarkets.com’s offering. It stated that the global market for Elahere, which is a treatment primarily for ovarian cancer, is anticipated to experience rapid […]",
      "url": "https://finnhub.io/api/news?id=b1a46e20d9b18ac03eeb4ae6bd70e25137702f520796f283b17c6249e752a21b"
    }
  }
]